Le Lézard
Classified in: Health
Subjects: TDS, FVT

AHM Takes a Prominent Role at the Upcoming Veeva Global Commercial & Medical Summit and Cvent Connect Conferences


NEW PROVIDENCE, N.J., April 28, 2017 /PRNewswire/ -- Continuing its leadership role in driving compliant interactions for the Life Sciences industry, AHM will be taking an eminent role in the following upcoming conferences with their strategic partners, Veeva Systems and Cvent.

* On May 7-9, Veeva will host its Global Commercial & Medical Summit in Philadelphia.  AHM is a Platinum Sponsor of the event and will be showcasing its Veeva Connector integration and co-presenting with a joint AHM-Veeva customer on the benefits of the combined solution. Collaboratively, AHM and Veeva provide an integrated offering to customers with an end-to-end solution for meetings and events management that ensures effective, compliant and high value engagements between a Life Sciences company and healthcare professionals (HCPs).

* On June 12-16 at the Mandalay Bay Convention Center in Las Vegas, NV, AHM will be exhibiting and speaking at Cvent CONNECT 2017. As a featured speaker at Cvent CONNECT 2017, AHM will provide its thought leadership within the Life Sciences track titled "Driving Compliance across All Meetings and Events." Cvent is a recognized leader in strategic meeting management technology. CONNECT is the premier event technology conference, bringing together event and hospitality professionals to collaborate, learn, and engage.  AHM's participation in both conferences highlights the strategic nature of the relationship between AHM and its key partners and the creation of an enterprise level solution for global meetings and events management.

For more information, visit AHM Events or email [email protected].

 

SOURCE AHM


These press releases may also interest you

at 16:10
Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the appointment of John Hayslip, M.D., an accomplished oncologist with deep clinical research, development, and...

at 16:10
Quantum-Si Incorporated ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Companytm, today announced that it will report financial results for the first quarter 2024 on Thursday, May 9, 2024. Company management will host a conference...

at 16:10
Dallas plastic surgeon and Meeting Chair, Dr. Rod J. Rohrich, hosts the 2024 Dallas Cosmetic Surgery and Medicine Meeting. This meeting, along with the Dallas Rhinoplasty Meeting which took place immediately afterwards, included panel discussions,...

at 16:00
PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") , a specialty pharmaceutical company, today announced receipt of a Complete Response Letter ("CRL") for its Priority Original Abbreviated New Drug Application ("ANDA") for Ketamine that was...

at 16:00
Ziegler, a privately held investment bank, is pleased to announce the publication of its new white paper, "Pediatric Healthcare: Key Themes and Sector Developments," highlighting the latest pediatric healthcare trends throughout multiple sub...

at 16:00
Partner Therapeutics, Inc. (PTx) announced publication of a comprehensive review by Dougan et al.1 in Cancers summarizing the mechanistic rationale and pre-clinical and clinical data regarding the use of Leukine (sargramostim; glycosylated,...



News published on and distributed by: